Retrospective Study of Brachytherapy

Recruiting

• Conditions: Brachytherapy; Uterine Cervical Neoplasms; Vulvar Cancer; Gynecologic Neoplasm; Uterine Neoplasms; Vaginal Cancer; Ovarian Neoplasms

• Registration Number: NCT05242861
• Lead Sponsor: Zhejiang Cancer Hospital

Brief Summary

Brachytherapy for gynecological cancers will be studied retrospectively.

Detailed Description

Not available

Study Timeline

• Status Verified: 2022-02
• Study First Submitted: 2022-02-06
• Study First Submitted QC: 2022-02-06
• Last Update Submitted: 2022-02-06
• Study First Posted: 2022-02-16
• Last Update Posted: 2022-02-16
• Study Start: 2022-02-20
• Primary Completion: 2024-12-31
• Study Completion: 2027-12-31

Recruitment & Eligibility

• Status: RECRUITING
• Sex: Female
• Target Recruitment: 300

Inclusion Criteria

• 18 - 80 female
• Underwent brachytherapy
• With gynecological cancer

Exclusion Criteria

• Refusal to enter this trial

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Overall survival rate	5-year	the percentage of participants in the group who survives

Secondary Outcome Measures

Name	Time	Method
Side effects	5-year	side effects associated with treatment
Progression-free survival rate	5-year	the percentage of participants in the group whose disease is likely to remain stable

Trial Locations

Locations (1)

Zhejiang Cancer Hospital; 🇨🇳 Hangzhou, Zhejiang, China